Carly Simon Discloses Parkinson’s Disease Diagnosis

New York, NY, July 27, 2026 —

Legendary singer-songwriter Carly Simon has publicly shared her diagnosis with Parkinson’s disease. The Grammy Award-winning artist revealed the news, adding to the millions worldwide living with the neurodegenerative disorder.

Parkinson’s disease is a chronic and progressive disorder that primarily affects the nervous system, particularly the brain. It is characterized by the gradual loss of neurons in a specific area of the brain called the substantia nigra, which are responsible for producing dopamine. Dopamine is a crucial neurotransmitter that helps regulate movement, mood, and other functions.

The exact cause of Parkinson’s disease remains unknown, but research suggests a combination of genetic and environmental factors may play a role. While there is currently no cure for the disease, a range of treatments are available to help manage its symptoms and improve the quality of life for those affected. These treatments can include medications to control motor symptoms, therapies such as physical, occupational, and speech therapy, and in some cases, surgical options like deep brain stimulation.

Globally, Parkinson’s disease affects an estimated 10 million people. The diagnosis often involves a combination of medical history, neurological examination, and sometimes response to medication. Symptoms can vary widely among individuals but commonly include tremors, rigidity, slowness of movement (bradykinesia), and postural instability. Over time, non-motor symptoms such as sleep disorders, depression, and cognitive changes can also emerge.

Simon’s announcement brings attention to the challenges faced by individuals with Parkinson’s and underscores the ongoing need for research, awareness, and support for this condition.

Story summarized from the original created by Rachel Sacks on nypost.com, see more information here.